✉news WorldEU Politics first seen 21 h ago, last 12 h ago, peak #5
Sanofi avoids EU antitrust fine after commitments on rival vaccine
Original: Sanofi avoids fine as EU accepts offer to end antitrust probe over disparaging rival vaccine
EU antitrust regulators have closed an investigation into Sanofi, accepting commitments from the French drugmaker to stop conduct that allegedly involved disparaging a rival vaccine. By offering binding changes to its behaviour, Sanofi avoided a fine. The case highlights how the European Commission can resolve competition concerns without penalising pharmaceutical companies that agree to reform their marketing and competitive practices.
Why now: The European Commission's decision to close a high-profile antitrust case against a major drugmaker without a fine is newsworthy for pharma and competition watchers.
SanofiEuropean CommissionEuropean Union
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/2238211